Clinical Trials · NCT01945788

Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

Phase
Phase 4
Recruitment status
Unknown
Sponsor
Bio Sidus SA
Enrollment
110
Start date
Jun 2013
Locations
1 site, Argentina
Primary endpoint
Change from baseline in Bone mineral Density at 6 months.
View Teriparatide compound reference